Moore Chris, Bull Charlotte, Darekar Angela, Wilson Daniel, Goodall Alex, Manoharan Prakash, Hoskin Peter, van Herk Marcel, Buckley David L, McHugh Damien J, Datta Anubhav, Dubec Michael J
Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.
Division of Cancer Sciences, The University of Manchester, Manchester, UK.
Phys Imaging Radiat Oncol. 2025 Jul 22;35:100814. doi: 10.1016/j.phro.2025.100814. eCollection 2025 Jul.
This work contributes to technical validation of apparent diffusion coefficient (ADC) as a biomarker of cancer. The aim was to evaluate ADC accuracy, random error, short-term and long-term repeatability and reproducibility, across multiple institutions using a room temperature phantom.
ADC measurements were made in a travelling room temperature diffusion weighted imaging (DWI) phantom on six scanners at four UK institutions over 18 months at six-month intervals. ADC bias measurements were calculated as the difference between measured and temperature corrected ground-truth ADC values and used to calculate mean ADC bias, isocentre ADC error estimate, short- and long-term intra-scanner repeatability as per the Quantitative Imaging Biomarkers Alliance (QIBA) DWI profiles, and inter-scanner reproducibility by calculating the 95 % limits of agreement for all ADC bias measurements.
The use of a room-temperature phantom with a magnetic resonance (MR) readable thermometer enabled ADC measurements without ice-water setup, considerably simplifying logistics with respect to multi-institution ADC quality assurance. Mean ADC bias across all scanners and sessions was <0.01 × 10 mm s (0.81 %); mean isocentre ADC error estimate was 1.43 %; average scanner short-term repeatability was <0.01 × 10 mm s (1 %). Reproducibility was 0.07 × 10 mm s (9 %).
Results indicated good ADC accuracy, repeatability and reproducibility; demonstrating the feasibility of transferring diagnostic DWI sequences between scanners from the same manufacturer, for use in multi-institution longitudinal studies, and assessing ADC with minimal quality control and harmonisation steps required.
本研究有助于对表观扩散系数(ADC)作为癌症生物标志物进行技术验证。目的是使用室温体模,在多个机构评估ADC的准确性、随机误差、短期和长期重复性及再现性。
在18个月内,每隔6个月在英国4家机构的6台扫描仪上,对一个移动的室温扩散加权成像(DWI)体模进行ADC测量。ADC偏差测量值计算为测量的ADC值与经温度校正的真实ADC值之间的差值,并用于计算平均ADC偏差、等中心ADC误差估计值、按照定量成像生物标志物联盟(QIBA)DWI曲线的扫描仪内短期和长期重复性,以及通过计算所有ADC偏差测量值的95%一致性界限来评估扫描仪间再现性。
使用带有磁共振(MR)可读温度计的室温体模,无需冰水设置即可进行ADC测量,大大简化了多机构ADC质量保证的后勤工作。所有扫描仪和测量环节的平均ADC偏差<0.01×10⁻³mm²/s(0.81%);平均等中心ADC误差估计值为1.43%;扫描仪平均短期重复性<0.01×10⁻³mm²/s(1%)。再现性为0.07×10⁻³mm²/s(9%)。
结果表明ADC具有良好的准确性、重复性和再现性;证明了在同一制造商的扫描仪之间转移诊断性DWI序列用于多机构纵向研究的可行性,以及在所需质量控制和协调步骤最少的情况下评估ADC的可行性。